Early research (Phase 1)Study completedNCT04223804
What this trial is testing
Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1
Who this might be right for
Human Immunodeficiency Virus (HIV)HIV InfectionHIV-1
AbbVie 41